Rhinoviral infection and asthma: The detection and management of rhinoviruses by airway epithelial cells

Clinical and Experimental Allergy

Volumn 44, Issue 1, 2014, Pages 20-28

  Parker, L C ^a   Stokes, C A ^a   Sabroe, I ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; PATTERN RECOGNITION RECEPTOR;

ASTHMA; AUTOPHAGY; BRONCHIOLITIS; CELL ENCAPSULATION; CYTOSOLIC FRACTION; DISEASE EXACERBATION; ECONOMIC EVALUATION; HEALTH CARE; HOMEOSTASIS; HUMAN; HUMAN RHINOVIRUS; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; REVIEW; RHINOVIRUS; RHINOVIRUS INFECTION; SEROTYPE; VIRUS INFECTION; VIRUS REPLICATION;

ASTHMA; AUTOPHAGY; BRONCHIOLITIS, VIRAL; HUMANS; IMMUNITY, INNATE; PICORNAVIRIDAE INFECTIONS; RECEPTORS, PATTERN RECOGNITION; RESPIRATORY MUCOSA; RHINOVIRUS; SEROTYPING; VIRUS INTERNALIZATION;

EID: 84890840518     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12182     Document Type: Review

References (122)

1. Longtin J, Winter AL, Heng D et al. Severe human rhinovirus outbreak associated with fatalities in a long-term care facility in Ontario, Canada. J Am Geriatr Soc 2010; 58:2036-8.
2. Louie JK, Yagi S, Nelson FA et al. Rhinovirus outbreak in a long term care facility for elderly persons associated with unusually high mortality. Clin Infect Dis 2005; 41:262-5.
3. Nicholson KG, Kent J, Hammersley V, Cancio E. Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden. BMJ 1997; 315:1060-4.
4. Pierangeli A, Scagnolari C, Selvaggi C et al. Rhinovirus frequently detected in elderly adults attending an emergency department. J Med Virol 2011; 83:2043-7.
5. Jennings LC, Anderson TP, Beynon KA et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax 2008; 63:42-8.
6. Johnstone J, Majumdar SR, Fox JD, Marrie TJ. Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation. Chest 2008; 134:1141-8.
7. Lieberman D, Shimoni A, Shemer-Avni Y, Keren-Naos A, Shtainberg R, Lieberman D. Respiratory viruses in adults with community-acquired pneumonia. Chest 2010; 138:811-6.
8. Kennedy JL, Turner RB, Braciale T, Heymann PW, Borish L. Pathogenesis of rhinovirus infection. Curr Opin Virol 2012; 2:287-93.
9. Kim WK, Gern JE. Updates in the relationship between human rhinovirus and asthma. Allergy Asthma Immunol Res 2012; 4:116-21.
10. Proud D. Role of rhinovirus infections in asthma. Asian Pac J Allergy Immunol 2011; 29:201-8.
11. Holt PG, Sly PD. Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment. Nat Med 2012; 18:726-35.
12. Johnston SL, Pattemore PK, Sanderson G et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995; 310:1225-9.
13. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993; 307:982-6.
14. Jackson DJ, Evans MD, Gangnon RE et al. Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am J Respir Crit Care Med 2012; 185:281-5.
15. Jackson DJ, Johnston SL. The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol 2010; 125:1178-87.
16. Khetsuriani N, Kazerouni NN, Erdman DD et al. Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol 2007; 119:314-21.
17. Kistler A, Avila PC, Rouskin S et al. Pan-viral screening of respiratory tract infections in adults with and without asthma reveals unexpected human coronavirus and human rhinovirus diversity. J Infect Dis 2007; 196:817-25.
18. Nicholson KG, Kent J, Hammersley V, Cancio E. Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: prospective cohort study. BMJ 1996; 313:1119-23.
19. Papadopoulos NG, Bates PJ, Bardin PG et al. Rhinoviruses infect the lower airways. J Infect Dis 2000; 181:1875-84.
20. Contoli M, Message SD, Laza-Stanca V et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 2006; 12:1023-6.
21. Wark PA, Johnston SL, Bucchieri F et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005; 201:937-47.
22. Forbes RL, Gibson PG, Murphy VE, Wark PA. Impaired type I and III interferon response to rhinovirus infection during pregnancy and asthma. Thorax 2012; 67:209-14.
23. Sykes A, Edwards MR, Macintyre J et al. Rhinovirus 16-induced IFN-alpha and IFN-beta are deficient in bronchoalveolar lavage cells in asthmatic patients. J Allergy Clin Immunol 2012; 129(1506-14):e6.
24. Baraldo S, Contoli M, Bazzan E et al. Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma. J Allergy Clin Immunol 2012; 130:1307-14.
25. Vareille M, Kieninger E, Alves MP et al. Impaired type I and type III interferon induction and rhinovirus control in human cystic fibrosis airway epithelial cells. Thorax 2012; 67:517-25.
26. Bochkov YA, Hanson KM, Keles S, Brockman-Schneider RA, Jarjour NN, Gern JE. Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol 2010; 3:69-80.
27. Lopez-Souza N, Favoreto S, Wong H et al. In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J Allergy Clin Immunol 2009; 123(1384-90):e2.
28. Denlinger LC, Sorkness RL, Lee WM et al. Lower airway rhinovirus burden and the seasonal risk of asthma exacerbation. Am J Respir Crit Care Med 2011; 184:1007-14.
29. Esper FP, Spahlinger T, Zhou L. Rate and influence of respiratory virus co-infection on pandemic (H1N1) influenza disease. J Infect 2011; 63:260-6.
30. Louie JK, Roy-Burman A, Guardia-Labar L et al. Rhinovirus associated with severe lower respiratory tract infections in children. Pediatr Infect Dis J 2009; 28:337-9.
31. Mallia P, Footitt J, Sotero R et al. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186:1117-24.
32. Unger BL, Faris AN, Ganesan S, Comstock AT, Hershenson MB, Sajjan US. Rhinovirus attenuates non-typeable Hemophilus influenzae-stimulated IL-8 responses via TLR2-dependent degradation of IRAK-1. PLoS Pathog 2012; 8:e1002969.
33. Arden KE, Faux CE, O'Neill NT et al. Molecular characterization and distinguishing features of a novel human rhinovirus (HRV) C, HRVC-QCE, detected in children with fever, cough and wheeze during 2003. J Clin Virol 2010; 47:219-23.
34. Hamparian VV, Colonno RJ, Cooney MK et al. A collaborative report: rhinoviruses-extension of the numbering system from 89 to 100. Virology 1987; 159:191-2.
35. Harvala H, McIntyre CL, McLeish NJ et al. High detection frequency and viral loads of human rhinovirus species A to C in fecal samples; diagnostic and clinical implications. J Med Virol 2012; 84:536-42.
36. Khan AG, Pichler J, Rosemann A, Blaas D. Human rhinovirus type 54 infection via heparan sulfate is less efficient and strictly dependent on low endosomal pH. J Virol 2007; 81:4625-32.
37. Lau SK, Yip CC, Tsoi HW et al. Clinical features and complete genome characterization of a distinct human rhinovirus (HRV) genetic cluster, probably representing a previously undetected HRV species, HRV-C, associated with acute respiratory illness in children. J Clin Microbiol 2007; 45:3655-64.
38. Palmenberg AC, Spiro D, Kuzmickas R et al. Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution. Science 2009; 324:55-9.
39. Bochkov YA, Palmenberg AC, Lee WM et al. Molecular modeling, organ culture and reverse genetics for a newly identified human rhinovirus C. Nat Med 2011; 17:627-32.
40. Bochkov YA, Gern JE. Clinical and molecular features of human rhinovirus C. Microbes Infect 2012; 14:485-94.
41. Ashraf S, Brockman-Schneider R, Bochkov YA, Pasic TR, Gern JE. Biological characteristics and propagation of human rhinovirus-C in differentiated sinus epithelial cells. Virology 2013; 436:143-9.
42. Hao W, Bernard K, Patel N et al. Infection and propagation of human rhinovirus C in human airway epithelial cells. J Virol 2012; 86:13524-32.
43. Bizzintino J, Lee WM, Laing IA et al. Association between human rhinovirus C and severity of acute asthma in children. Eur Respir J 2011; 37:1037-42.
44. Iwane MK, Prill MM, Lu X et al. Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children. J Infect Dis 2011; 204:1702-10.
45. Miller EK, Edwards KM, Weinberg GA et al. A novel group of rhinoviruses is associated with asthma hospitalizations. J Allergy Clin Immunol 2009; 123(98-104):e1.
46. Linder JE, Kraft DC, Mohamed Y et al. Human rhinovirus C: age, season, and lower respiratory illness over the past 3 decades. J Allergy Clin Immunol 2013; 131:69-77 e1-6.
47. Dreschers S, Dumitru CA, Adams C, Gulbins E. The cold case: are rhinoviruses perfectly adapted pathogens? Cell Mol Life Sci 2007; 64:181-91.
48. Snyers L, Zwickl H, Blaas D. Human rhinovirus type 2 is internalized by clathrin-mediated endocytosis. J Virol 2003; 77:5360-9.
49. Grassme H, Riehle A, Wilker B, Gulbins E. Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms. J Biol Chem 2005; 280:26256-62.
50. Khan AG, Pickl-Herk A, Gajdzik L, Marlovits TC, Fuchs R, Blaas D. Human rhinovirus 14 enters rhabdomyosarcoma cells expressing icam-1 by a clathrin-, caveolin-, and flotillin-independent pathway. J Virol 2010; 84:3984-92.
51. Bentley JK, Newcomb DC, Goldsmith AM, Jia Y, Sajjan US, Hershenson MB. Rhinovirus activates interleukin-8 expression via a Src/p110beta phosphatidylinositol 3-kinase/Akt pathway in human airway epithelial cells. J Virol 2007; 81:1186-94.
52. Lau C, Wang X, Song L et al. Syk associates with clathrin and mediates phosphatidylinositol 3-kinase activation during human rhinovirus internalization. J Immunol 2008; 180:870-80.
53. Newcomb DC, Sajjan U, Nanua S et al. Phosphatidylinositol 3-kinase is required for rhinovirus-induced airway epithelial cell interleukin-8 expression. J Biol Chem 2005; 280:36952-61.
54. Newcomb DC, Sajjan US, Nagarkar DR et al. Human rhinovirus 1B exposure induces phosphatidylinositol 3-kinase-dependent airway inflammation in mice. Am J Respir Crit Care Med 2008; 177:1111-21.
55. Gern JE, Vrtis R, Grindle KA, Swenson C, Busse WW. Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med 2000; 162:2226-31.
56. Grunberg K, Smits HH, Timmers MC et al. Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am J Respir Crit Care Med 1997; 156:609-16.
57. Triantafilou K, Vakakis E, Richer EA, Evans GL, Villiers JP, Triantafilou M. Human rhinovirus recognition in non-immune cells is mediated by Toll-like receptors and MDA-5, which trigger a synergetic pro-inflammatory immune response. Virulence 2011; 2:22-9.
58. Hewson CA, Jardine A, Edwards MR, Laza-Stanca V, Johnston SL. Toll-like receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells. J Virol 2005; 79:12273-9.
59. Slater L, Bartlett NW, Haas JJ et al. Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog 2010; 6:e1001178.
60. Wang Q, Nagarkar DR, Bowman ER et al. Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J Immunol 2009; 183:6989-97.
61. Parker LC, Prestwich EC, Ward JR et al. A phosphatidylserine species inhibits a range of TLR- but not IL-1beta-induced inflammatory responses by disruption of membrane microdomains. J Immunol 2008; 181:5606-17.
62. Morris GE, Parker LC, Ward JR et al. Cooperative molecular and cellular networks regulate Toll-like receptor-dependent inflammatory responses. FASEB J 2006; 20:2153-5.
63. Kato A, Favoreto S Jr, Avila PC, Schleimer RP. TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J Immunol 2007; 179:1080-7.
64. Sadik CD, Bachmann M, Pfeilschifter J, Muhl H. Activation of interferon regulatory factor-3 via toll-like receptor 3 and immunomodulatory functions detected in A549 lung epithelial cells exposed to misplaced U1-snRNA. Nucleic Acids Res 2009; 37:5041-56.
65. Proud D, Hudy MH, Wiehler S et al. Cigarette smoke modulates expression of human rhinovirus-induced airway epithelial host defense genes. PLoS ONE 2012; 7:e40762.
66. Clingan JM, Ostrow K, Hosiawa KA, Chen ZJ, Matloubian M. Differential roles for RIG-I-like receptors and nucleic acid-sensing TLR pathways in controlling a chronic viral infection. J Immunol 2012; 188:4432-40.
67. Holm CK, Jensen SB, Jakobsen MR et al. Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING. Nat Immunol 2012; 13:737-43.
68. Prendergast AJ, Klenerman P, Goulder PJ. The impact of differential antiviral immunity in children and adults. Nat Rev Immunol 2012; 12:636-48.
69. Edwards MR, Bartlett NW, Hussell T, Openshaw P, Johnston SL. The microbiology of asthma. Nat Rev Microbiol 2012; 10:459-71.
70. Goulding J, Snelgrove R, Saldana J et al. Respiratory infections: do we ever recover? Proc Am Thorac Soc 2007; 4:618-25.
71. Fader CM, Colombo MI. Autophagy and multivesicular bodies: two closely related partners. Cell Death Differ 2009; 16:70-8.
72. Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature 2011; 469:323-35.
73. Delgado MA, Elmaoued RA, Davis AS, Kyei G, Deretic V. Toll-like receptors control autophagy. EMBO J 2008; 27:1110-21.
74. Xu Y, Jagannath C, Liu XD, Sharafkhaneh A, Kolodziejska KE, Eissa NT. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 2007; 27:135-44.
75. Anand PK, Tait SW, Lamkanfi M et al. TLR2 and RIP2 pathways mediate autophagy of Listeria monocytogenes via extracellular signal-regulated kinase (ERK) activation. J Biol Chem 2011; 286:42981-91.
76. Shi CS, Kehrl JH. MyD88 and Trif target Beclin 1 to trigger autophagy in macrophages. J Biol Chem 2008; 283:33175-82.
77. Shi CS, Kehrl JH. Traf6 and A20 differentially regulate TLR4-induced autophagy by affecting the ubiquitination of Beclin 1. Autophagy 2010; 6:986-7.
78. Gorbea C, Makar KA, Pauschinger M et al. A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy. J Biol Chem 2010; 285:23208-23.
79. Lee HK, Lund JM, Ramanathan B, Mizushima N, Iwasaki A. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 2007; 315:1398-401.
80. Jounai N, Takeshita F, Kobiyama K et al. The Atg5 Atg12 conjugate associates with innate antiviral immune responses. Proc Natl Acad Sci USA 2007; 104:14050-5.
81. Tal MC, Sasai M, Lee HK, Yordy B, Shadel GS, Iwasaki A. Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proc Natl Acad Sci USA 2009; 106:2770-5.
82. Jackson WT, Giddings TH Jr, Taylor MP et al. Subversion of cellular autophagosomal machinery by RNA viruses. PLoS Biol 2005; 3:e156.
83. Klein KA, Jackson WT. Human rhinovirus 2 induces the autophagic pathway and replicates more efficiently in autophagic cells. J Virol 2011; 85:9651-4.
84. Miller S, Krijnse-Locker J. Modification of intracellular membrane structures for virus replication. Nat Rev Microbiol 2008; 6:363-74.
85. Brabec-Zaruba M, Berka U, Blaas D, Fuchs R. Induction of autophagy does not affect human rhinovirus type 2 production. J Virol 2007; 81:10815-7.
86. Quiner CA, Jackson WT. Fragmentation of the Golgi apparatus provides replication membranes for human rhinovirus 1A. Virology 2010; 407:185-95.
87. Ryter SW, Choi AM. Autophagy in the lung. Proc Am Thorac Soc 2010; 7:13-21.
88. Mallia P, Johnston SL. How viral infections cause exacerbation of airway diseases. Chest 2006; 130:1203-10.
89. Chen ZH, Kim HP, Sciurba FC et al. Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS ONE 2008; 3:e3316.
90. Kim HP, Wang X, Chen ZH et al. Autophagic proteins regulate cigarette smoke-induced apoptosis: protective role of heme oxygenase-1. Autophagy 2008; 4:887-95.
91. Ryter SW, Chen ZH, Kim HP, Choi AM. Autophagy in chronic obstructive pulmonary disease: homeostatic or pathogenic mechanism? Autophagy 2009; 5:235-7.
92. Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, Deretic V. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 2004; 119:753-66.
93. Harris J, De Haro SA, Master SS et al. T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity 2007; 27:505-17.
94. Sabroe I, Parker LC, Dockrell DH, Davies DE, Dower SK, Whyte MK. Targeting the networks that underpin contiguous immunity in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175:306-11.
95. Martin LJ, Gupta J, Jyothula SS et al. Functional variant in the autophagy-related 5 gene promotor is associated with childhood asthma. PLoS ONE 2012; 7:e33454.
96. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012; 18:716-25.
97. Jackson DJ, Sykes A, Mallia P, Johnston SL. Asthma exacerbations: origin, effect, and prevention. J Allergy Clin Immunol 2011; 128:1165-74.
98. Johnston SL. Innate immunity in the pathogenesis of virus-induced asthma exacerbations. Proc Am Thorac Soc 2007; 4:267-70.
99. Singanayagam A, Joshi PV, Mallia P, Johnston SL. Viruses exacerbating chronic pulmonary disease: the role of immune modulation. BMC Med 2012; 10:27.
100. Bedke N, Haitchi HM, Xatzipsalti M, Holgate ST, Davies DE. Contribution of bronchial fibroblasts to the antiviral response in asthma. J Immunol 2009; 182:3660-7.
101. Cakebread JA, Xu Y, Grainge C et al. Exogenous IFN-beta has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus. J Allergy Clin Immunol 2011; 127(1148-54):e9.
102. Wang Q, Miller DJ, Bowman ER et al. MDA5 and TLR3 initiate pro-inflammatory signaling pathways leading to rhinovirus-induced airways inflammation and hyperresponsiveness. PLoS Pathog 2011; 7:e1002070.
103. Pishdadian A, Varasteh AR, Sankian M. Type 2 innate lymphoid cells: friends or foes-role in airway allergic inflammation and asthma. J Allergy (Cairo) 2012; 2012:130937.
104. Spits H, Cupedo T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol 2012; 30:647-75.
105. Chang YJ, Kim HY, Albacker LA et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 2011; 12:631-8.
106. Monticelli LA, Sonnenberg GF, Abt MC et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 2011; 12:1045-54.
107. Mjosberg J, Spits H. Type 2 innate lymphoid cells-new members of the "type 2 franchise" that mediate allergic airway inflammation. Eur J Immunol 2012; 42:1093-6.
108. Bennett JA, Prince LR, Parker LC et al. Pellino-1 selectively regulates epithelial cell responses to rhinovirus. J Virol 2012; 86:6595-604.
109. Stokes CA, Ismail S, Dick EP et al. Role of interleukin-1 and MyD88-dependent signaling in rhinovirus infection. J Virol 2011; 85:7912-21.
110. Edwards MR, Hewson CA, Laza-Stanca V et al. Protein kinase R, IkappaB kinase-beta and NF-kappaB are required for human rhinovirus induced pro-inflammatory cytokine production in bronchial epithelial cells. Mol Immunol 2007; 44:1587-97.
111. Rudd BD, Burstein E, Duckett CS, Li X, Lukacs NW. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J Virol 2005; 79:3350-7.
112. Wilkinson TM, Hurst JR, Perera WR, Wilks M, Donaldson GC, Wedzicha JA. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD. Chest 2006; 129:317-24.
113. Papi A, Bellettato CM, Braccioni F et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006; 173:1114-21.
114. Chaudhuri N, Paiva C, Donaldson K, Duffin R, Parker LC, Sabroe I. Diesel exhaust particles override natural injury-limiting pathways in the lung. Am J Physiol Lung Cell Mol Physiol 2010; 299:L263-71.
115. Ward JR, Francis SE, Marsden L et al. A central role for monocytes in Toll-like receptor-mediated activation of the vasculature. Immunology 2009; 128:58-68.
116. Marriott HM, Gascoyne KA, Gowda R et al. Interleukin-1beta regulates CXCL8 release and influences disease outcome in response to Streptococcus pneumoniae, defining intercellular cooperation between pulmonary epithelial cells and macrophages. Infect Immun 2012; 80:1140-9.
117. Piper SC, Ferguson GJ, Kay L et al. The role of interleukin-1 and interleukin-18 in pro-inflammatory and anti-viral responses to rhinovirus in primary bronchial epithelial cells. PLoS ONE 2013; 8:e63365.
118. Jacobs SR, Damania B. NLRs, inflammasomes, and viral infection. J Leukoc Biol 2012; 92:469-77.
119. Jefferies C, Wynne C, Higgs R. Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease? Nat Rev Immunol 2011; 11:617-25.
120. Jiang Z, Johnson HJ, Nie H, Qin J, Bird TA, Li X. Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex. J Biol Chem 2003; 278:10952-6.
121. Chang M, Jin W, Sun SC. Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine production. Nat Immunol 2009; 10:1089-95.
122. Smith H, Liu XY, Dai L et al. The role of TBK1 and IKKepsilon in the expression and activation of Pellino 1. Biochem J 2011; 434:537-48.